GAITHERSBURG, MD / ACCESSWIRE / June 2, 2016 / OpGen, Inc. (NASDAQ: OPGN), a precision medicine company using molecular
diagnostics and bioinformatics to combat infectious disease, announced today that Kevin Krenitsky, president, will present at the
6th Annual LD Micro Invitational conference on June 7, 2016 at 2:30 p.m. Pacific Time. The conference is being held from June 7- 9
at the Luxe Sunset Boulevard Hotel in Los Angeles.
A webcast of the presentation will be available in the investor relations section of the Company's website, www.opgen.com, and
will be archived for 90 days following the presentation.
About OpGen
OpGen, Inc. is developing and deploying precision medicine tools to combat infectious disease in global healthcare settings,
helping physicians improve patient outcomes by providing more rapid information about life-threatening infections and decreasing
the spread of infections caused by multidrug-resistant microorganisms. OpGen offers a full portfolio of in vitro diagnostic
products and clinical laboratory services that employ state-of-the-art molecular diagnostics and bioinformatics. Its QuickFISH®
products are a suite of FDA-cleared and CE-marked diagnostics used to rapidly detect pathogens in positive blood cultures. Clinical
laboratory services utilize the Acuitas® products, including the MDRO Gene Test, the Resistome Test, microbial Whole Genome
Sequence Analysis and Acuitas Lighthouse™ bioinformatics system designed to detect, type, track and trend antibiotic resistant
organisms in real-time. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually
(Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe. For those interested in
attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
Contacts:
OpGen
Michael Farmer Director, Marketing (240) 813-1284 mfarmer@opgen.com InvestorRelations@opgen.com Investor Relations
LHA Kim Sutton Golodetz (212) 838-3777 kgolodetz@lhai.com or Bruce Voss (310) 691-7100 bvoss@lhai.com
OpGen media
MacDougall Biomedical Communications Cammy Duong 781-591-3443 cduong@macbiocom.com
SOURCE: OpGen, Inc. via LD Micro
